BDNFVal66met polymorphism: A potential bridge between depression and thrombosis

European Heart Journal

Volumn 38, Issue 18, 2017, Pages 1426-1435

  Amadio, Patrizia ^a   Colombo, Gualtiero I ^a   Tarantino, Eva ^b   Gianellini, Sara ^a   Ieraci, Alessandro ^b   Brioschi, Maura ^a   Banfi, Cristina ^a   Werba, José P ^a   Parolari, Alessandro ^c   Lee, Francis S ^d   Tremoli, Elena ^a,b   Barbieri, Silvia S ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

BDNFVal66Met polymorphism; Depression; Platelet; Thrombosis; Vascular inflammation

Indexed keywords

ANTITHROMBOCYTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CAY 10591; METHIONINE; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG; VALINE; CELL SURFACE RECEPTOR; NERVE PROTEIN; SIRT1 PROTEIN, MOUSE; SORCS2 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ACUTE HEART INFARCTION; ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTIC TISSUE; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY THROMBOSIS; CASE REPORT; DEPRESSION; ENZYME ACTIVATION; FEMALE; GENE MUTATION; GENE SEQUENCE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE FUNCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; ANXIETY DISORDER; AORTA; BLOOD CLOTTING; CAROTID ARTERY; DISEASE MODEL; GENETICS; HEART MUSCLE ISCHEMIA; HETEROZYGOTE; HOMOZYGOTE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOSIS; TRANSGENIC MOUSE;

ANIMALS; ANXIETY DISORDERS; AORTA; BLOOD COAGULATION; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAROTID ARTERIES; CAROTID ARTERY THROMBOSIS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MICE, TRANSGENIC; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NERVE TISSUE PROTEINS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES; THROMBOSIS;

EID: 85019769623     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv655     Document Type: Article

References (42)

1. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014;129:1350-1369.
2. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-226.
3. Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013;2013:695925.
4. Bondy B. Common genetic factors for depression and cardiovascular disease. Dialogues Clin Neurosci 2007;9:19-28.
5. Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, Wang S, Ibanez CF, Rafii S, Hempstead BL. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000;127:4531-4540.
6. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006;110:167-173.
7. Bozzini S, Gambelli P, Boiocchi C, Schirinzi S, Falcone R, Buzzi P, Storti C, Falcone C. Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 2009;24:813-818.
8. Liu YQ, Su GB, Duan CH, Wang JH, Liu HM, Feng N, Wang QX, Liu XE, Zhang J. Brainderived neurotrophic factor gene polymorphisms are associated with coronary artery diseaserelated depression and antidepressant response. Mol Med Rep 2014;10:3247-3253.
9. Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R. Interaction between stress and the BDNFVal66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 2014;12:7.
10. Stahelova A, Petrkova J, Motakova N, Taborsky M, Mrazek F, Petrek M. The BDNF Val66Met polymorphism is not associated with myocardial infarction in Czech patients. Cytokine 2011;53:13-14.
11. Jiang H, Wang R, Liu Y, Zhang Y, Chen ZY. BDNFVal66Met polymorphism is associated with unstable angina. Clin Chim Acta 2009;400:3-7.
12. Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, Hengstenberg C, Erdmann J, Schunkert H, Seshadri S, Vasan RS, Assimes TL, Deloukas P, Holm H, Kathiresan S, Konig IR, McPherson R, Reilly MP, Roberts R, Samani NJ, Stewart AF. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc 2015;4:e001544.
13. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006;314:140-143.
14. Yu H, Wang DD, Wang Y, Liu T, Lee FS, Chen ZY. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci 2012;32:4092-4101.
15. Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol 2000;20:2019-2023.
16. Lind SE, Smith DB, Janmey PA, Stossel TP. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 1986;78:736-742.
17. Janmey PA, Lamb JA, Ezzell RM, Hvidt S, Lind SE. Effects of actin filaments on fibrin clot structure and lysis. Blood 1992;80:928-936.
18. Kwiatkowski DJ. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999;11:103-108.
19. Maes M, Scharpe S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P, Suy E. Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992;24:183-192.
20. Anastasia A, Deinhardt K, Chao MV, Will NE, Irmady K, Lee FS, Hempstead BL, Bracken C. Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Commun 2013;4:2490.
21. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, MayoMW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23:2369-2380.
22. Barbieri SS, Amadio P, Gianellini S, Tarantino E, Zacchi E, Veglia F, Howe LR, Weksler BB, Mussoni L, Tremoli E. Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner. Circulation 2012;126:1373-1384.
23. Breitenstein A, Stein S, Holy EW, Camici GG, Lohmann C, Akhmedov A, Spescha R, Elliott PJ, Westphal CH, Matter CM, Luscher TF, Tanner FC. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovasc Res 2011;89:464-472.
24. Shen MY, Hsiao G, Liu CL, Fong TH, Lin KH, Chou DS, Sheu JR. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Br J Haematol 2007;139:475-485.
25. Shimizu E, Hashimoto K, Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004;126B:122-123.
26. Cerletti C, Tamburrelli C, Izzi B, Gianfagna F, de Gaetano G. Platelet-leukocyte interactions in thrombosis. Thromb Res 2012;129:263-266.
27. Ehrlich D, Humpel C. Platelets in psychiatric disorders. World J Psychiatry 2012;2:91-94.
28. Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost 2009;7:573-581.
29. Abe N, Uchida S, Otsuki K, Hobara T, Yamagata H, Higuchi F, Shibata T, Watanabe Y. Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res 2011;45:1106-1112.
30. Breitenstein A, Wyss CA, Spescha RD, Franzeck FC, Hof D, Riwanto M, Hasun M, Akhmedov A, von Eckardstein A, MaierW, Landmesser U, Luscher TF, Camici GG. Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease. PLoS ONE 2013;8:e53106.
31. Winnik S, Auwerx J, Sinclair DA, Matter CM. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J 2015;36:3404-3412.
32. CONVERGE consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015;523:588-591.
33. Kilic U, Gok O, Bacaksiz A, Izmirli M, Elibol-Can B, Uysal O. SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases. PLoS One 2014;9:e90428.
34. Consiglio CR, da Silveira SJ, Monticielo OA, Xavier RM, Brenol JCT, Chies JAB. SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus. Mol Biol Rep 2014;41:4233-4239.
35. Wang L, Miller C, Swarthout RF, Rao M, Mackman N, Taubman MB. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood 2009;113:705-713.
36. Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, Ganz P, Kinlay S. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2013;2:e003103.
37. Shi Y, You J, Yuan Y, Zhang X, Li H, Hou G. Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin Neurosci 2010;64:249-254.
38. Hoirisch-Clapauch S, Nardi AE, Gris JC, Brenner B. Mental disorders and thrombotic risk. Semin Thromb Hemost 2013;39:943-949.
39. Casella JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature 1981;293:302-305.
40. Liu Y, Yin H, Jiang Y, Xue M, Guo C, Shi D, Chen K. Correlation between platelet gelsolin and platelet activation level in acute myocardial infarction rats and intervention effect of effective components of Chuanxiong rhizome and red peony root. Evid Based Complement Alternat Med 2013;2013:985746.
41. Liu Y, Yin HJ, Chen KJ. Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease. Chin J IntegrMed 2011;17:587-592.
42. Vasconcellos CA, Lind SE. Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood 1993;82:3648-3657.